Nitrosamine Impurities Application Guide - Confidently Detect and Quantify Mutagenic Impurities in APIs and Drug Products

Příručky, Prezentace | 2020 | Agilent TechnologiesInstrumentace
GC/MSD, GC/MS/MS, HeadSpace, GC/SQ, GC/QQQ, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/QQQ
Zaměření
Farmaceutická analýza
Výrobce
Agilent Technologies
Klíčová slova
PDF verze ke stažení a čtení
 

Podobná PDF

Toggle
Nitrosamines Analysis in Pharmaceuticals Using Single Quadrupole GC/MS or Triple Quadrupole GC/MS Consumables workflow ordering guide R1 N N R2 R O 2 R 1 R N N 2 R 1 R O R 2 1 N N N N…
Klíčová slova
nitrosamine, nitrosaminenitrosamines, nitrosaminesndma, ndmandea, ndeamylist, mylistfavorite, favoriteneipa, neipandipa, ndipadrug, drugppm, ppmitems, itemsinlet, inletclick, clickreplacement, replacementsupplies
Application Note Pharma and Biopharma Quantification of Nitrosamine Impurities in Metformin Using Agilent GC/MS/MS Instrumentation Authors Soma Dasgupta, Vivek Dhyani, Samir Vyas, and Melissa Churley, Agilent Technologies, Inc. Abstract Since June 2018, several drugs were recalled due to the presence…
Klíčová slova
ndma, ndmandea, ndeacounts, countsacquisition, acquisitiondrug, drugname, namendba, ndbanitrosamine, nitrosaminemin, minneipa, neipandipa, ndipaweighed, weighedϭϭϯ, ϭϭϯїϱϲ͘ϭ͕, їϱϲ͘ϭ͕time
Application Note Pharma & Biopharma Analysis of Five Nitrosamine Impurities in Drug Products and Drug Substances Using Agilent GC/MS/MS Instrumentation Authors Soma Dasgupta, Lalith Hansoge, Vivek Dhyani, Samir Vyas, and Melissa Churley Agilent Technologies, Inc. Abstract This application note highlights…
Klíčová slova
relative, relativeresponses, responsesndba, ndbaneipa, neipandipa, ndipandma, ndmaotr, otrndea, ndeastd, stdfda, fdacounts, countsconcentration, concentrationacquisition, acquisitiondrug, drugimpurities
Application Note No. 62 Analysis of Pharmaceuticals’ Impurity - Regulations and Analysis for Carcinogenic Substances Dheeraj Handique *a), Nitish Suryawanshi *a), Crystal Yeong *b), Cynthia Lahey *b), Shailendra Rane *a), Deepti Bhandarkar *a), Anant Lohar *a), Gao Jie san *c),…
Klíčová slova
ndma, ndmandea, ndeacarcinogenic, carcinogenicsubstances, substancesmutagenic, mutagenicmms, mmsems, emsimpurity, impuritymode, modeims, imsdrug, drugmutagenicity, mutagenicityolmesartan, olmesartanndba, ndbapharmaceuticals
Další projekty
Sledujte nás
Další informace
WebinářeO násKontaktujte násPodmínky užití
LabRulez s.r.o. Všechna práva vyhrazena.